Cited by 23

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Brain Cells Release Calreticulin That Attracts and Activates Microglia, and Inhibits Amyloid Beta Aggregation and Neurotoxicity

Reid, Kyle M., Kitchener, Emily J. A., Butler, Claire A., Cockram, Tom O. J., Brown, Guy C.·2022·Frontiers in Immunology

Abstract

Calreticulin is a chaperone, normally found in the endoplasmic reticulum, but can be released by macrophages into the extracellular medium. It is also found in cerebrospinal fluid bound to amyloid beta (Aβ). We investigated whether brain cells release calreticulin, and whether extracellular calreticulin had any effects on microglia and neurons relevant to neuroinflammation and neurodegeneration. We found that microglia release nanomolar levels of calreticulin when inflammatory-activated with lipopolysaccharide, when endoplasmic reticulum stress was induced by tunicamycin, or when cell death was induced by staurosporine, and that neurons release calreticulin when crushed. Addition of nanomolar levels of extracellular calreticulin was found to chemoattract microglia, and activate microglia to release cytokines TNF-α, IL-6 and IL-1β, as well as chemokine (C-C motif) ligand 2. Calreticulin blocked Aβ fibrillization and modified Aβ oligomerization, as measured by thioflavin T fluorescence and transmission electron microscopy. Extracellular calreticulin also altered microglial morphology and proliferation, and prevented Aβ-induced neuronal loss in primary neuron-glial cultures. Thus, calreticulin is released by microglia and neurons, and acts: as an alarmin to recruit and activate microglia, as an extracellular chaperone to prevent Aβ aggregation, and as a neuroprotectant against Aβ neurotoxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2022.859686

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 58

  1. Coppolino, 1998, Calreticulin, Int J Biochem Cell Biol, 30, 10.1016/S1357-2725(97)00153-2 · DOI
  2. Gardai, 2005, Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells Through Trans-Activation of LRP on the Phagocyte, Cell, 123, 10.1016/j.cell.2005.08.032 · DOI · Paper page
  3. Schcolnik-Cabrera, 2019, Calreticulin in Phagocytosis and Cancer: Opposite Roles in Immune Response Outcomes, Apoptosis, 24, 10.1007/s10495-019-01532-0 · DOI
  4. Martins, 2010, Surface-Exposed Calreticulin in the Interaction Between Dying Cells and Phagocytes, Ann N Y Acad Sci, 1209, 77, 10.1111/j.1749-6632.2010.05740.x · DOI
  5. Hong, 2010, Functional Analysis of Recombinant Calreticulin Fragment 39–272: Implications for Immunobiological Activities of Calreticulin in Health and Disease, J Immunol, 185, 10.4049/jimmunol.1000536 · DOI
  6. Païdassi, 2011, Investigations on the C1q-Calreticulin-Phosphatidylserine Interactions Yield New Insights Into Apoptotic Cell Recognition, J Mol Biol, 408, 10.1016/j.jmb.2011.02.029 · DOI
  7. Vandivier, 2002, Role of Surfactant Proteins a, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex, J Immunol, 169, 10.4049/jimmunol.169.7.3978 · DOI
  8. Stuart, 1997, The C1q and Collectin Binding Site Within C1q Receptor (Cell Surface Calreticulin), Immunopharmacology, 38, 73, 10.1016/S0162-3109(97)00076-3 · DOI
  9. Ogden, 2001, C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and CD91 Initiates Macropinocytosis and Uptake of Apoptotic Cells, J Exp Med, 194, 10.1084/jem.194.6.781 · DOI
  10. Feng, 2018, Programmed Cell Removal by Calreticulin in Tissue Homeostasis and Cancer, Nat Commun, 9, 1, 10.1038/s41467-018-05211-7 · DOI
  11. Cockram, 2019, Calreticulin and Galectin-3 Opsonise Bacteria for Phagocytosis by Microglia, Front Immunol, 10, 10.3389/fimmu.2019.02647 · DOI
  12. Bianchi, 2007, Damps, Pamps and Alarmins: All We Need to Know About Danger, J Leukoc Biol, 81, 1, 10.1189/jlb.0306164 · DOI · Paper page
  13. Bajor, 2011, Modulatory Role of Calreticulin as Chaperokine for Dendritic Cell-Based Immunotherapy, Clin Exp Immunol, 165, 10.1111/j.1365-2249.2011.04423.x · DOI
  14. Bak, 2008, Calreticulin Requires an Ancillary Adjuvant for the Induction of Efficient Cytotoxic T Cell Responses, Mol Immunol, 45, 10.1016/j.molimm.2007.08.020 · DOI
  15. Dabbs, 2010, Extracellular Chaperones, 1
  16. Wyatt, 2013, Extracellular Chaperones and Proteostasis, Annu Rev Biochem, 82, 295, 10.1146/annurev-biochem-072711-163904 · DOI
  17. Wyatt, 2012, Roles of Extracellular Chaperones in Amyloidosis, J Mol Biol, 421, 499, 10.1016/j.jmb.2012.01.004 · DOI
  18. Erickson, 2005, In Cerebrospinal Fluid ER Chaperones Erp57 and Calreticulin Bind β-Amyloid, Biochem Biophys Res Commun, 332, 10.1016/j.bbrc.2005.04.090 · DOI
  19. Houen, 2008, Interaction of Calreticulin With Amyloid Beta Peptide 1-42, Protein Pept Lett, 15, 10.2174/092986608783330459 · DOI
  20. Blasi, 1990, Immortalization of Murine Microglial Cells by a V-Raf / V-Myc Carrying Retrovirus, J Neuroimmunol, 27, 10.1016/0165-5728(90)90073-V · DOI
  21. Shen, 2016, Glioma-Induced Inhibition of Caspase-3 in Microglia Promotes a Tumor-Supportive Phenotype, Nat Immunol, 17, 10.1038/ni.3545 · DOI
  22. Carrillo-Jimenez, 2018, Effective Knockdown of Gene Expression in Primary Microglia With Sirna and Magnetic Nanoparticles Without Cell Death or Inflammation, Front Cell Neurosci, 12, 10.3389/fncel.2018.00313 · DOI
  23. Allendorf, 2020, Activated Microglia Desialylate Their Surface, Stimulating Complement Receptor 3-Mediated Phagocytosis of Neurons, Glia, 68, 10.1002/glia.23757 · DOI
  24. Neniskyte, 2011, Neuronal Death Induced by Nanomolar Amyloid β is Mediated by Primary Phagocytosis of Neurons by Microglia, J Biol Chem, 286, 10.1074/jbc.M111.267583 · DOI
  25. Naiki, 1989, Fluorometric Determination of Amyloid Fibrils In Vitro Using the Fluorescent Dye, Thioflavine T, Anal Biochem, 177, 10.1016/0003-2697(89)90046-8 · DOI
  26. Abdullahi, 2017, Modeling Acute Er Stress In Vivo and In Vitro, Shock, 47, 10.1097/SHK.0000000000000759 · DOI
  27. Simenc, 2012, Staurosporine Induces Different Cell Death Forms in Cultured Rat Astrocytes, Radiol Oncol, 46, 10.2478/v10019-012-0036-9 · DOI
  28. Torres-Platas, 2014, Morphometric Characterization of Microglial Phenotypes in Human Cerebral Cortex, J Neuroinflamm, 11, 10.1186/1742-2094-11-12 · DOI
  29. Dello Russo, 2018, The Human Microglial HMC3 Cell Line: Where do We Stand? A Systematic Literature Review, J Neuroinflamm, 15, 1, 10.1186/s12974-018-1288-0 · DOI
  30. Wakelin, 2006, “Dirty Little Secrets”—Endotoxin Contamination of Recombinant Proteins, Immunol Lett, 106, 1, 10.1016/j.imlet.2006.04.007 · DOI
  31. Cardoso, 2007, Polymyxin B as Inhibitor of LPS Contamination of Schistosoma Mansoni Recombinant Proteins in Human Cytokine Analysis, Microb Cell Fact, 6, 10.1186/1475-2859-6-1 · DOI
  32. Fricker, 2012, Primary Phagocytosis of Viable Neurons by Microglia Activated With LPS or Aβ is Dependent on Calreticulin/LRP Phagocytic Signalling, J Neuroinflamm, 9, 697, 10.1186/1742-2094-9-196 · DOI · Paper page
  33. Orr, 2003, Low Density Lipoprotein Receptor-Related Protein is a Calreticulin Coreceptor That Signals Focal Adhesion Disassembly, J Cell Biol, 161, 10.1083/jcb.200302069 · DOI
  34. Williams, 1992, A Novel Mechanism for Controlling the Activity of Alpha 2-Macroglobulin Receptor/Low Density Lipoprotein Receptor-Related Protein. Multiple Regulatory Sites for 39-Kda Receptor-Associated Protein, J Biol Chem, 267, 10.1016/S0021-9258(19)50384-2 · DOI · Paper page
  35. Henn, 2009, The Suitability of BV2 Cells as Alternative Model System for Primary Microglia Cultures or for Animal Experiments Examining Brain Inflammation, ALTEX, 26, 83, 10.14573/altex.2009.2.83 · DOI · Paper page
  36. Ohsawa, 2007, Involvement of P2X4 and P2Y12 Receptors in ATP-Induced Microglial Chemotaxis, Glia, 55, 10.1002/glia.20489 · DOI
  37. Lu, 2015, Functional Roles of Calreticulin in Cancer Biology, BioMed Res Int, 2015, 1, 10.1155/2015/526524 · DOI
  38. Alur, 2009, Suppressive Roles of Calreticulin in Prostate Cancer Growth and Metastasis, Am J Pathol, 175, 10.2353/ajpath.2009.080417 · DOI
  39. Weng, 2015, Calreticulin Regulates VEGF-a in Neuroblastoma Cells, Mol Neurobiol, 52, 10.1007/s12035-014-8901-8 · DOI
  40. Gold, 2006, Overview of the Role for Calreticulin in the Enhancement of Wound Healing Through Multiple Biological Effects, J Investig Dermatol Symp Proc, 11, 57, 10.1038/sj.jidsymp.5650011 · DOI
  41. Amin, 2021, Aβ Receptors Specifically Recognize Molecular Features Displayed by Fibril Ends and Neurotoxic Oligomers, Nat Commun, 12, 3451, 10.1038/s41467-021-23507-z · DOI
  42. Obeid, 2007, Calreticulin Exposure Dictates the Immunogenicity of Cancer Cell Death, Nat Med, 13, 54, 10.1038/nm1523 · DOI · Paper page
  43. Galluzzi, 2017, Immunogenic Cell Death in Cancer and Infectious Disease, Nat Rev Immunol, 17, 97, 10.1038/nri.2016.107 · DOI · Paper page
  44. Eggleton, 1994, Calreticulin is Released From Activated Neutrophils and Binds to C1q and Mannan-Binding Protein, Clin Immunol Immunopathol, 72, 10.1006/clin.1994.1160 · DOI
  45. Pike, 1998, Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth, J Exp Med, 188, 10.1084/JEM.188.12.2349 · DOI
  46. Brifault, 2017, Shedding of Membrane-Associated LDL Receptor-Related Protein-1 From Microglia Amplifies and Sustains Neuroinflammation, J Biol Chem, 292, 10.1074/JBC.M117.798413 · DOI
  47. Li, 2015, Dendritic Cell Activation and Maturation Induced by Recombinant Calreticulin Fragment 39-272, Int J Clin Exp Med, 8
  48. Williams, 2006, Beyond Lectins: The Calnexin/Calreticulin Chaperone System of the Endoplasmic Reticulum, J Cell Sci, 119, 10.1242/jcs.02856 · DOI
  49. Mannini, 2012, Molecular Mechanisms Used by Chaperones to Reduce the Toxicity of Aberrant Protein Oligomers, Proc Natl Acad Sci USA, 109, 10.1073/pnas.1117799109 · DOI
  50. Narayan, 2012, Amyloid-β Oligomers are Sequestered by Both Intracellular and Extracellular Chaperones, Biochemistry, 51, 10.1021/bi301277k · DOI
  51. Lively, 2018, Microglia Responses to Pro-Inflammatory Stimuli (LPS, Ifnγ+Tnfα) and Reprogramming by Resolving Cytokines (IL-4, IL-10), Front Cell Neurosci, 12, 10.3389/FNCEL.2018.00215/FULL · DOI
  52. Wollmer, 2001, ATP and Adenosine Induce Ramification of Microglia In Vitro, J Neuroimmunol, 115, 19, 10.1016/S0165-5728(01)00257-0 · DOI
  53. Füger, 2017, Microglia Turnover With Aging and in an Alzheimer’s Model via Long-Term In Vivo Single-Cell Imaging, Nat Neurosci, 20, 10.1038/nn.4631 · DOI · Paper page
  54. Pike, 1999, Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth, Blood, 94, 10.1182/blood.v94.7.2461.419a26_2461_2468 · DOI
  55. Town, 2005, The Microglial “Activation” Continuum: From Innate to Adaptive Responses, J Neuroinflamm, 2, 1, 10.1186/1742-2094-2-24 · DOI
  56. Dubbelaar, 2018, The Kaleidoscope of Microglial Phenotypes, Front Immunol, 9, 10.3389/fimmu.2018.01753 · DOI · Paper page
  57. Chen, 2016, Microglia and Neuroprotection, J Neurochem, 136, 10.1111/jnc.13062 · DOI
  58. Bellver-Landete, 2019, Microglia are an Essential Component of the Neuroprotective Scar That Forms After Spinal Cord Injury, Nat Commun, 10, 1, 10.1038/s41467-019-08446-0 · DOI

Cited by

Sorted by citations

Metadata

Authors
Reid, K. M., Kitchener, E. J. A., Butler, C. A., Cockram, T. O. J., & Brown, G. C.
Venue
Frontiers in Immunology
Published
2022-04-20
Volume
13
ISSN
1664-3224
Cited by
23
References
3
Funders
Biotechnology and Biological Sciences Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review